DENALI THERAPEUTICS INC's ticker is and the CUSIP is 24823R955. A total of 2 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $52 | +2500.0% | 2,300 | +2200.0% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 100 | -50.0% | 0.00% | – |
| Q2 2022 | $5,000 | -99.4% | 200 | -99.0% | 0.00% | -100.0% |
| Q4 2021 | $909,000 | +1876.1% | 20,400 | +3300.0% | 0.00% | – |
| Q3 2021 | $46,000 | -2.1% | 600 | 0.0% | 0.00% | – |
| Q2 2021 | $47,000 | -92.5% | 600 | +445.5% | 0.00% | -100.0% |
| Q1 2021 | $628,000 | – | 110 | +5400.0% | 0.00% | – |
| Q4 2020 | $0 | – | 2 | -90.9% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 22 | -12.0% | 0.00% | – |
| Q1 2020 | $43,000 | -46.2% | 25 | -45.7% | 0.00% | – |
| Q4 2019 | $80,000 | -67.9% | 46 | -71.8% | 0.00% | -100.0% |
| Q3 2019 | $249,000 | – | 163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 110 | $628,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |